Sandoz Group AG (SDZXF)

OTCMKTS · Delayed Price · Currency is USD
73.00
+0.49 (0.68%)
At close: Jan 6, 2026
77.23%
Market Cap33.03B
Revenue (ttm)10.59B
Net Income (ttm)227.00M
Shares Outn/a
EPS (ttm)0.52
PE Ratio145.53
Forward PE21.00
Dividend0.73 (1.01%)
Ex-Dividend DateApr 17, 2025
Volume440
Average Volume266
Open72.12
Previous Close72.51
Day's Range72.12 - 73.00
52-Week Range36.68 - 73.45
Beta0.25
RSI73.65
Earnings DateFeb 25, 2026

About Sandoz Group AG

Sandoz Group AG develops, manufactures, and markets generic pharmaceuticals and biosimilars worldwide. The company covers therapeutic areas, including cardiovascular, central nervous system, oncology, infectious diseases, pain and respiratory, diabetes, immunology, endocrinology, hematology, and ophthalmology. It also provides a portfolio of active pharmaceutical ingredients and finished dosage forms. The company was founded in 1886 and is headquartered in Basel, Switzerland. [Read more]

Sector Healthcare
Founded 1886
Employees 22,049
Stock Exchange OTCMKTS
Ticker Symbol SDZXF
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.